A. Spinillo et al., ASYMPTOMATIC GENITOURINARY CHLAMYDIA-TRACHOMATIS INFECTION IN WOMEN SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Obstetrics and gynecology, 83(6), 1994, pp. 1005-1010
Objective: To evaluate the prevalence of asymptomatic Chlamydia tracho
matis genitourinary infection in women with human immunodeficiency vir
us (HIV) infection. Methods: The prevalence of asymptomatic chlamydial
genitourinary infection in HIV-seropositive women was compared with b
oth HIV-seronegative controls and women with unknown HIV status. Chlam
ydia trachomatis was isolated in cell culture from endocervical and ur
ethral specimens. Results: The prevalence of genitourinary C trachomat
is infection among HIV-seropositive women was 18.3% (21 of 115), a rat
e significantly higher than in both HIV-negative women (11 of 136; P =
.016) and controls with unknown HIV status (18 of 326; P = .0001). Cr
ude odds ratios for endocervical and urethral chlamydial infection in
HIV-seropositive women compared to HIV-seronegative controls were 2.6
(95% confidence interval [CI] 1.13-6.08) and 3.3 (95% CI 1.15-9.67), r
espectively. After adjustment for variables related to sexual habits,
there was no difference in the risk of cervical C trachomatis infectio
n between HIV-seropositive cases and HIV-seronegative controls (Mantel
-Haenszel odds ratio 1.04, 95% CI 0.93-1.14; P =.41). Finally, in HIV-
seropositive patients, both the severity of immuno-suppression evaluat
ed by CD4+, CD8+, and total lymphocyte counts and the detection of p24
HIV-related antigen did not correlate with the presence of chlamydial
infection. Conclusions: Women infected with HIV are at high risk for
asymptomatic genitourinary chlamydial colonization. To prevent a possi
ble ''epidemic'' of pelvic inflammatory disease, appropriate screening
programs and therapeutic strategies should be planned.